The CBD Regulatory Landscape Is Shifting Fast

The 2018 Farm Bill legalized hemp-derived CBD at the federal level. But seven years later, the FDA still hasn't established a regulatory framework for CBD in food, beverages, or dietary supplements. This gap has created a $6+ billion market operating in a regulatory gray zone — where products are widely sold but quality standards are voluntary.

The result: enormous variation in product quality, inconsistent state laws, and a constantly evolving policy landscape. Custom CBD Labs tracks these changes — federal proposals, state-level regulations, enforcement actions, and the industry's push for clear quality standards.

Key Terms

CBD (Cannabidiol)

A non-intoxicating cannabinoid extracted from hemp. CBD does not produce a "high" and is the primary compound in most hemp-derived wellness products. Federally legal when sourced from hemp containing less than 0.3% THC.

Certificate of Analysis (COA)

A lab report from an accredited third-party laboratory verifying a product's cannabinoid potency, plus screening for contaminants such as pesticides, heavy metals, and residual solvents. The industry gold standard for quality verification.

cGMP (Current Good Manufacturing Practice)

FDA-enforced manufacturing standards that ensure product consistency, cleanliness, and quality control. While not yet mandatory for CBD, reputable manufacturers comply voluntarily.

Hemp vs. Marijuana

Both are Cannabis sativa. The legal distinction is THC content: hemp contains 0.3% THC or less by dry weight (legal under the Farm Bill); marijuana exceeds that threshold and remains federally controlled.